疏肝舒筋法针刺治疗周期性乳痛症的临床疗效观察OA
Observation on the Clinical Efficacy of Liver-soothing and Tendon-relaxing Acupuncture in the Treatment of Cyclical Mastalgia
目的:基于周期性乳痛症(CM)肝郁气滞、筋脉痹阻的病机特点,评价疏肝舒筋针刺疗法对CM的临床疗效,为针刺治疗CM提供科学依据.方法:采用多中心、随机、单盲、假针刺对照的试验设计,选取2022年7月~2023年12月在3个试验中心就诊的CM患者108例,按1:1比例随机分为针刺组和假针刺组各54例.针刺组的针刺取穴方案为屋翳、乳根、膻中、阿是穴、天宗、膈俞、肝俞、合谷、三阴交、太冲,假针刺组使用钝头针在非经非穴点操作.两组患者均在月经前2周开始治疗,月经期间暂停治疗,每周3次,1个月经周期内进行6次治疗,连续3个月经周期.主要评估指标为乳腺疼痛视觉模拟评分(VAS)日均评分,次要指标包括疼痛天数、世界卫生组织生活质量简表(WHOQOL-BREF)评分以及乳腺超声检测指标,包括乳腺腺体厚度、导管直径以及乳腺组织弹性硬度E值.结果:治疗后各时点,两组患者VAS评分和疼痛天数均较治疗前下降(P<0.05),针刺组优于假针刺组(P<0.05);两组患者WHOQOL-BREF总分均较治疗前有所提高(P<0.05),针刺组高于假针刺组(P<0.05);两组患者的双侧乳腺横切面与纵切面的厚度、导管直径均较治疗前减少(P<0.05),两组间进行比较差异无统计学意义(P>0.05);针刺组患者双侧乳腺中央区、内带、中带、外带的弹性E值较治疗前减少(P<0.05),假针刺组较治疗前无变化(P>0.05),针刺组双侧乳腺各区域弹性E值小于假针刺组(P<0.05).结论:疏肝舒筋针刺可有效缓解CM患者的乳痛症状,可调节乳腺组织的物理特性,具有良好的远期效果,且能改善患者的生活质量,为进一步的临床实践和研究提供了科学依据.
Objective:Based on the pathogenesis characteristics of liver qi stagnation and meridian obstruction in cyclical mastalgia(CM),this study aimed to evaluate the clinical efficacy of liver-soothing and tendon-relaxing acupuncture for CM and to provide a scientific basis for acupuncture treatment of CM.Methods:A multi-center,randomized,single-blind,sham acupuncture-controlled trial design was adopted.A total of 108 CM patients who were treated at three trial centers from July 2022 to December 2023 were selected and randomly divided into an acupuncture group and a sham acupuncture group in a 1:1 ratio,with 54 cases in each group.The acupuncture point prescription for the acupuncture group included Wuyi(ST 15),Rugen(ST 18),Tanzhong(CV 17),Ashi points,Tianzong(SI 11),Geshu(BL 17),Ganshu(BL 18),Hegu(LI 4),Sanyinjiao(SP 6),and Taichong(LR 3).The sham acupuncture group received sham needling with blunt-tipped needles at non-meridian and non-acupoint locations.Patients in both groups began treatment two weeks before menstruation,paused during menstruation,and received three sessions per week,totaling six treatments within one menstrual cycle,for three consecutive menstrual cycles.The primary outcome measure was the mean daily Visual Analog Scale(VAS)score for breast pain,while secondary outcomes included the number of pain days,the World Health Organization Quality of Life-BREF(WHOQOL-BREF)score,and breast ultrasound findings encompassing breast gland thickness,breast duct diameter,and breast tissue elasticity(E value).Results:At each time point after treatment,the mean daily VAS scores and pain days of both groups decreased compared to before treatment(P<0.05),and the acupuncture group was superior to the sham acupuncture group(P<0.05).The total WHOQOL-BREF scores of both groups increased compared to before treatment(P<0.05),and the score of the acupuncture group was higher than that of the sham acupuncture group(P<0.05).The thickness of the bilateral breast on transverse and longitudinal sections and the duct diameter in both groups decreased compared to before treatment(P<0.05),with no statistically significant difference between the two groups(P>0.05).The elasticity E values of the central,inner,middle,and outer regions of the bilateral breast in the acupuncture group decreased compared to before treatment(P<0.05),while there was no change in the sham acupuncture group(P>0.05).The elasticity E values of each region of the bilateral breast in the acupuncture group were lower than those in the sham acupuncture group(P<0.05).Conclusion:Liver-soothing and tendon-relaxing acupuncture can effectively alleviate breast pain symptoms in patients with CM,modulate the physical properties of breast tissue,produce good long-term effects,and improve patients'quality of life,providing a scientific basis for further clinical practice and research.
申斌;李响;方依依;张蕊;秦岩;高印红;张玉良;于川
北京市平谷区中医医院,北京 101200北京市平谷区中医医院,北京 101200北京市平谷区中医医院,北京 101200北京市平谷区中医医院,北京 101200北京市平谷区中医医院,北京 101200北京市平谷区黄松峪乡社区卫生服务中心,北京 101200北京市平谷区夏各庄镇社区卫生服务中心,北京 101200北京市平谷区中医医院,北京 101200
医药卫生
周期性乳痛症针刺疏肝舒筋法乳腺腺体厚度乳腺导管直径
cyclical mastalgiaacupunctureliver-soothing and tendon-relaxing acupuncturebreast gland thicknessbreast duct diameter
《中医康复》 2026 (10)
59-65,7
首都卫生发展科研专项基金(2022-3-7132)
评论